Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15a pseudogene 20 (RPS15AP20) is a processed pseudogene in Homo sapiens, derived from the ribosomal protein S15a gene. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically lack regulatory elements necessary for proper gene expression and often contain disabling mutations[6][5]. RPS15AP20 does not encode a functional protein and is not considered a receptor, enzyme, or therapeutic target[2][9]. Some pseudogenes, particularly those related to ribosomal proteins, may produce non-coding RNAs with regulatory functions, such as modulation of signaling pathways or serving as competing endogenous RNAs, but there is no experimental evidence for such a role specific to RPS15AP20 at present[1][2][5][6]. Thus, it is listed in scientific databases as a non-coding pseudogene without known molecular function or disease relevance[2][9][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 20 (RPS15AP20).